Acadia Healthcare Company, Inc. (ACHC) News

Acadia Healthcare Company, Inc. (ACHC): $80.07

3.35 (+4.37%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter ACHC News Items

ACHC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ACHC News Highlights

  • ACHC's 30 day story count now stands at 6.
  • Over the past 7 days, the trend for ACHC's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • SEEL, SLS and DRUG are the most mentioned tickers in articles about ACHC.

Latest ACHC News From Around the Web

Below are the latest news stories about ACADIA HEALTHCARE COMPANY INC that investors may wish to consider to help them evaluate ACHC as an investment opportunity.

When Should You Buy Acadia Healthcare Company, Inc. (NASDAQ:ACHC)?

Acadia Healthcare Company, Inc. ( NASDAQ:ACHC ), might not be a large cap stock, but it received a lot of attention...

Yahoo | September 20, 2022

Thomas Jefferson University and Acadia Healthcare Establish Primary Affiliation Agreement

PHILADELPHIA & FRANKLIN, Tenn., September 15, 2022--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and Thomas Jefferson University today announced that Acadia’s Belmont Behavioral Health Hospital has entered into a formal affiliation agreement with Thomas Jefferson University’s Sidney Kimmel Medical College and Jefferson Health in Philadelphia, Pennsylvania, to further teaching and clinical care opportunities for students in behavioral healthcare.

Yahoo | September 15, 2022

Acadia Healthcare Appoints Dr. Nasser Khan to Lead Its CTC Business

FRANKLIN, Tenn., September 14, 2022--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the appointment of Dr. Nasser Khan, M.D., as Operations Group President for its Comprehensive Treatment Center (CTC) business. Dr. Khan will oversee Acadia’s network of 145 CTC facilities and associated services. He joined Acadia on September 6th following the retirement of the CTC business’ previous group president. Dr. Khan will report to John Hollinsworth, EVP Operations.

Yahoo | September 14, 2022

Select Acadia Healthcare Hospitals to Participate in Clinical Trial for Acute Suicidal Ideation and Behavior in Major Depression Drug

FRANKLIN, Tenn., September 14, 2022--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that select facilities from its network of acute care behavioral health hospitals will participate in a registration directed trial to study participants with suicidal ideation and behavior with major depression. This study is sponsored by Seelos Therapeutics (NASDAQ: SEEL) for its SLS-002 investigational drug. Acadia hospitals that meet the criteria for participation as clinical trial sites will

Yahoo | September 14, 2022

Minnesota health department OKs Fairview plan for psychiatric hospital at St. Paul's Bethesda

The Minnesota Department of Health on Monday approved a $62 million proposal by Fairview Health Services and Tennessee-based Acadia Healthcare Co. Inc. to open a 144-bed mental hospital at the site of the shuttered Bethesda Hospital in St. Paul. The Pioneer Press has a report on the decision, which will allow construction of the hospital to continue despite a statewide moratorium on new hospital beds. "The public review of this proposal shows how much need there is for additional mental health beds in Minnesota,” said Minnesota Commissioner of Health Jan Malcolm in a statement.

Yahoo | September 13, 2022

Seelos Therapeutics Announces the Participation of Acadia Healthcare in the Registration Directed Study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced the participation of Acadia Healthcare Company, Inc. (Nasdaq: ACHC) in the registration directed Proof of Concept study of SLS-002 (intranasal racemic ketamine) for Acute Suicidal Ideation and Behavior (ASIB) in patients with Major Depressive Disorder (MDD).

Yahoo | September 13, 2022

Stocks At New Highs: Fertilizer Maker, Mental Health Provider Hit Buy Points

Few stocks hit 52-week highs amid a big market sell-off to end the week. Two stocks at new highs are industry leaders, allowing their stocks to rise with them. CF Industries (CF) broke out of a cup base, hitting the 113.58 buy point, and is in the 5% buy zone to 119.26. The IBD 50 Top 10 and Big Cap...

Yahoo | August 26, 2022

Acadia Healthcare (ACHC) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Yahoo | August 25, 2022

Is Now The Time To Put Acadia Healthcare Company (NASDAQ:ACHC) On Your Watchlist?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Yahoo | August 21, 2022

Acadia Healthcare (ACHC) Stock Up 3% on Q2 Earnings Beat

Acadia Healthcare's (ACHC) second-quarter results benefit from a strong-performing U.S. business. A raised 2022 guidance with respect to EPS bodes well.

Yahoo | August 9, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5939 seconds.